Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Myocarditis in humans and in experimental animal models
P Błyszczuk - Frontiers in cardiovascular medicine, 2019 - frontiersin.org
Myocarditis is defined as an inflammation of the cardiac muscle. In humans, various
infectious and non-infectious triggers induce myocarditis with a broad spectrum of …
infectious and non-infectious triggers induce myocarditis with a broad spectrum of …
[HTML][HTML] Current trends in the pharmacological management of Chagas disease
Chagas disease (CD) is a tropical neglected illness, affecting mainly populations of low
socioeconomic status in Latin America. An estimated 6 to 8 million people worldwide are …
socioeconomic status in Latin America. An estimated 6 to 8 million people worldwide are …
ROS and Trypanosoma cruzi: Fuel to infection, poison to the heart
The activation of macrophage respiratory burst in response to infection with Trypanosoma
cruzi inflicts oxidative damage to the host's tissues. For decades, the role of reactive oxygen …
cruzi inflicts oxidative damage to the host's tissues. For decades, the role of reactive oxygen …
[HTML][HTML] Resveratrol-like compounds as SIRT1 activators
The sirtuin 1 (SIRT1) activator resveratrol has emerged as a promising candidate for the
prevention of vascular oxidative stress, which is a trigger for endothelial dysfunction …
prevention of vascular oxidative stress, which is a trigger for endothelial dysfunction …
Effects of resveratrol supplementation on cardiac remodeling in hypertensive patients: a randomized controlled clinical trial
X Zheng, J Hai, Y Yang, C Zhang, X Ma, B Kong… - Hypertension …, 2023 - nature.com
Resveratrol (RES) has been demonstrated to be protective in the cardiovascular system in
animal studies, but the evidence is limited in humans. The purpose of the study was to …
animal studies, but the evidence is limited in humans. The purpose of the study was to …
Review of pharmacological options for the treatment of Chagas disease
F Lascano, F García Bournissen… - British journal of clinical …, 2022 - Wiley Online Library
Chagas disease (CD) is a worldwide problem, with over 8 million people infected in both
rural and urban areas. CD was first described over a century ago, but only two drugs are …
rural and urban areas. CD was first described over a century ago, but only two drugs are …
Small molecule mediators of host-T. cruzi-environment interactions in Chagas disease
G Kwakye-Nuako, CE Middleton, LI McCall - PLoS Pathogens, 2024 - journals.plos.org
Small molecules (less than 1,500 Da) include major biological signals that mediate host-
pathogen-microbiome communication. They also include key intermediates of metabolism …
pathogen-microbiome communication. They also include key intermediates of metabolism …
Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy
Chagas disease is caused by infection with the protozoan Trypanosoma cruzi and affects
over 8 million people worldwide. In spite of a powerful innate and adaptive immune …
over 8 million people worldwide. In spite of a powerful innate and adaptive immune …
AMP-activated protein kinase and host defense against infection
P Silwal, JK Kim, JM Yuk, EK Jo - International journal of molecular …, 2018 - mdpi.com
5′-AMP-activated protein kinase (AMPK) plays diverse roles in various physiological and
pathological conditions. AMPK is involved in energy metabolism, which is perturbed by …
pathological conditions. AMPK is involved in energy metabolism, which is perturbed by …
Cardiomyocyte infection by Trypanosoma cruzi promotes innate immune response and glycolysis activation
Introduction Chagas cardiomyopathy, a disease caused by Trypanosoma cruzi (T. cruzi)
infection, is a major contributor to heart failure in Latin America. There are significant gaps in …
infection, is a major contributor to heart failure in Latin America. There are significant gaps in …